Dr. John Vanmetre, M.D.
What this data tells you about Dr. Vanmetre
Dr. John Vanmetre is an optician in Victoria, TX, with 20 years in practice. Based on federal Medicare data, Dr. Vanmetre performed 6,760 Medicare services across 3,409 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vanmetre received a total of $1,361 from 27 pharmaceutical and/or device companies across 57 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vanmetre is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity | 1,418 | $61 | $149 |
| Office visit, established patient (20-29 min) | 379 | $63 | $110 |
| Nursing facility visit, low complexity | 354 | $56 | $125 |
| Hospital follow-up visit, high complexity | 301 | $92 | $200 |
| Office visit, established patient (30-39 min) | 282 | $90 | $162 |
| Nursing facility visit, moderate complexity | 281 | $79 | $160 |
| Ceftriaxone antibiotic injection | 268 | $0 | $28 |
| Comprehensive metabolic blood panel | 252 | $10 | $61 |
| Hospital discharge management, 30+ min | 212 | $87 | $198 |
| Initial hospital admission, high complexity | 202 | $133 | $299 |
| Automated urinalysis | 198 | $2 | $32 |
| Lipid panel (cholesterol and triglycerides) | 194 | $13 | $42 |
| Complete blood count (CBC) with differential | 176 | $8 | $32 |
| Injection, ketorolac tromethamine, per 15 mg | 161 | $0 | $22 |
| Hemoglobin A1c test (diabetes monitoring) | 156 | $9 | $64 |
| Annual depression screening | 152 | $18 | $30 |
| Annual alcohol misuse screening, 5 to 15 minutes | 149 | $18 | $35 |
| Advance care planning consultation, first 30 min | 131 | $75 | $100 |
| Drug injection, under skin or into muscle | 128 | $10 | $30 |
| Annual wellness visit, follow-up | 120 | $124 | $150 |
| Chronic care management, first 20 min/month | 114 | $48 | $100 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 108 | $102 | $150 |
| Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | 96 | $102 | $225 |
| Blood draw (venipuncture) | 95 | $8 | $15 |
| Complete blood count (CBC), automated | 95 | $6 | $30 |
| Injection, methylprednisolone acetate, 80 mg | 83 | $8 | $44 |
| Urine microalbumin (protein) analysis | 68 | $6 | $30 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | 56 | $47 | $200 |
| Regadenoson injection (Lexiscan) for heart stress test | 56 | $44 | $150 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 55 | $4 | $20 |
| Home visit, established patient, low complexity | 46 | $56 | $175 |
| Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | 44 | $65 | $110 |
| Electrocardiogram (EKG), 12-lead | 31 | $10 | $75 |
| Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | 31 | $40 | $100 |
| Transitional care management services for problem of high complexity | 29 | $212 | $300 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 28 | $1 | $20 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 26 | $41 | $100 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 24 | $16 | $29 |
| New patient office or other outpatient visit, 15-29 minutes | 18 | $48 | $110 |
| Transitional care management services for problem of at least moderate complexity | 16 | $156 | $225 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 16 | $246 | $875 |
| Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | 15 | $33 | $60 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 14 | $334 | $1,650 |
| Nuclear medicine study of kidney and blood flow | 14 | $161 | $500 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 14 | $47 | $539 |
| New patient office visit (30-44 min) | 14 | $61 | $162 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | 14 | $24 | $80 |
| Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries | 14 | $187 | $1,000 |
| Flu vaccine administration | 12 | $30 | $50 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Vanmetre is a clinical cardiology specialist, with above-average Medicare volume (top 11% in TX), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Vanmetre experienced with hospital follow-up visit, moderate complexity?
Does Dr. Vanmetre receive payments from pharmaceutical companies?
How do Dr. Vanmetre's costs compare to other opticians in Victoria?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology